Introducing Sophos Endpoint for Legacy Platforms – Sophos Information
Legacy working programs which have reached end-of-support typically lack safety features and updates which are current in newer programs, making ...
Tag: Introducing
Introducing Gemma 3 270M: The compact mannequin for hyper-efficient AI
The previous few months have been an thrilling time for the Gemma household of open fashions. We launched Gemma 3 ...
Introducing Amazon Bedrock AgentCore Gateway: Remodeling enterprise AI agent device growth
To satisfy their duties, AI Brokers want entry to numerous capabilities together with instruments, information shops, immediate templates, and different ...
Introducing Gemma 3 270M: The compact mannequin for hyper-efficient AI
The previous couple of months have been an thrilling time for the Gemma household of open fashions. We launched Gemma ...
Introducing LangExtract: A Gemini powered info extraction library
In at the moment's data-rich world, useful insights are sometimes locked away in unstructured textual content, equivalent to detailed medical ...
Introducing Amazon Bedrock AgentCore Browser Device
At AWS Summit New York Metropolis 2025, Amazon Internet Companies (AWS) introduced the preview of Amazon Bedrock AgentCore browser device, ...
Introducing Opal: describe, create, and share your AI mini-apps
It’s by no means been simpler to harness the ability of AI fashions, prompts, and instruments into working AI purposes. ...
Introducing Inner Assault Floor Administration (IASM) for Sophos Managed Danger – Sophos Information
Cyber threats proceed to evolve, and organizations should keep forward by fortifying their defenses. Whereas exterior assault floor administration (EASM) ...
Introducing Gemma 3n: The developer information
The first Gemma mannequin launched early final 12 months and has since grown right into a thriving Gemmaverse of over ...
Introducing TxGemma: Open fashions to enhance therapeutics improvement
Creating a brand new therapeutic is dangerous, notoriously gradual, and might value billions of {dollars}. 90% of drug candidates fail ...
